Corrections Corp. (CXW) Comments on DOJ Action; Says Findings Don't Match with Independent Studies
- Stocks tumble on new coronavirus variant fear
- Moderna (MRNA) Shares Rally 11% on 'Nu' Concerns, Analyst Sees mRNA Technology Adapting Much Quicker to New COVID Variant
- DiDi (DIDI) Stock Falls on Report China Seeks Delisting From US Amid Data Security Concerns
- Apple (AAPL) on Pace to Sell Over 10 Million iPhones for Black Friday - Wedbush
- Buy Tech Winners on Variant Fears - Wedbush
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Corrections Corp. (NYSE: CXW) sent out the following commentary today to StreetInsider.com with respect to the Deparment of Justice's move to phase-out the use of private prisons:
We value our partners, and we will continue to work with them, both through the types of management solutions we’ve provided for more than three decades, as well as new, innovative opportunities we’ve been exploring in recent years in a proactive effort to meet their evolving needs. For example, our real estate-only solution helps government deliver needed facility space in a cost-effective manner while providing its own staffing and management services. We’ve also greatly expanded our residential re-entry offerings, which help inmates prepare to successfully return to their communities. In fact, this spring we won a re-bid of a Federal Bureau of Prisons (BOP) contract for these critical services. It’s important to note that today’s announcement relates only to BOP correctional facilities, which make up seven percent of our business.
The Inspector General’s report used to buttress this decision has significant flaws. The report’s authors freely admit that they “were unable to evaluate all of the factors that contributed to the underlying data,” and they failed to account for the impact of elements such as population demographics or the scope and efficacy of efforts to mitigate contraband. The findings simply don’t match up to the numerous independent studies that show our facilities to be equal or better with regard to safety and quality, or the excellent feedback we get from our partners at all levels of government.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Moderna (MRNA) Extends Gain, Up 22%
- Longeveron (LGVN) Halted on LUDP, Up 40.5%
- Why Zoom (ZM) Stock is Up 9% Today
Create E-mail Alert Related CategoriesCorporate News, Litigation, Momentum Movers, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!